172 related articles for article (PubMed ID: 21484434)
1. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5.
Matsukawa T; Wang X; Liu R; Wortham NC; Onuki Y; Kubota A; Hida A; Kowa H; Fukuda Y; Ishiura H; Mitsui J; Takahashi Y; Aoki S; Takizawa S; Shimizu J; Goto J; Proud CG; Tsuji S
Neurogenetics; 2011 Aug; 12(3):259-61. PubMed ID: 21484434
[No Abstract] [Full Text] [Related]
2. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
[TBL] [Abstract][Full Text] [Related]
3. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
[TBL] [Abstract][Full Text] [Related]
4. [Leukoencephalopathy with vanishing white matter: a clinical case of adult onset].
Pato Pato A; Lorenzo González JR; Cimas Hernando I; Rodríguez-Constenla I
Neurologia; 2009 Sep; 24(7):504-5. PubMed ID: 21469262
[No Abstract] [Full Text] [Related]
5. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease.
Wu Y; Pan Y; Du L; Wang J; Gu Q; Gao Z; Li J; Leng X; Qin J; Wu X; Jiang Y
J Hum Genet; 2009 Feb; 54(2):74-7. PubMed ID: 19158808
[TBL] [Abstract][Full Text] [Related]
6. Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4.
Kanbayashi T; Saito F; Matsukawa T; Oba H; Hokkoku K; Hatanaka Y; Tsuji S; Sonoo M
Clin Genet; 2015 Oct; 88(4):401-3. PubMed ID: 25600065
[No Abstract] [Full Text] [Related]
7. Identification of a Missense Variant in the EIF2B3 Gene Causing Vanishing White Matter Disease with Antenatal-Onset but Mild Symptoms and Long-Term Survival.
Khorrami M; Khorram E; Yaghini O; Rezaei M; Hejazifar A; Iravani O; Yazdani V; Riahinezhad M; Kheirollahi M
J Mol Neurosci; 2021 Nov; 71(11):2405-2414. PubMed ID: 33687620
[TBL] [Abstract][Full Text] [Related]
8. An autopsy case of infantile-onset vanishing white matter disease related to an EIF2B2 mutation (V85E) in a hemizygous region.
Hata Y; Kinoshita K; Miya K; Hirono K; Ichida F; Yoshida K; Nishida N
Int J Clin Exp Pathol; 2014; 7(6):3355-62. PubMed ID: 25031760
[TBL] [Abstract][Full Text] [Related]
9. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
[TBL] [Abstract][Full Text] [Related]
10. Eif2b3 mutants recapitulate phenotypes of vanishing white matter disease and validate novel disease alleles in zebrafish.
Lee YR; Kim SH; Ben-Mahmoud A; Kim OH; Choi TI; Lee KH; Ku B; Eum J; Kee Y; Lee S; Cha J; Won D; Lee ST; Choi JR; Lee JS; Kim HD; Kim HG; Bonkowsky JL; Kang HC; Kim CH
Hum Mol Genet; 2021 Apr; 30(5):331-342. PubMed ID: 33517449
[TBL] [Abstract][Full Text] [Related]
11. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
[TBL] [Abstract][Full Text] [Related]
12. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
Alsalem A; Shaheen R; Alkuraya FS
Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
[TBL] [Abstract][Full Text] [Related]
13. Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course.
Sambati L; Agati R; Bacci A; Bianchi S; Capellari S
Neurol Sci; 2013 Jul; 34(7):1235-8. PubMed ID: 22729508
[TBL] [Abstract][Full Text] [Related]
14. Vanishing white matter disease with mutations in EIF2B5 gene.
Sharma S; Ajij M; Singh V; Aneja S
Indian J Pediatr; 2015 Jan; 82(1):93-5. PubMed ID: 25230711
[TBL] [Abstract][Full Text] [Related]
15. Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations.
Slynko I; Nguyen S; Hamilton EMC; Wisse LE; de Esch IJP; de Graaf C; Bruning JB; Proud CG; Abbink TEM; van der Knaap MS
Mol Genet Genomic Med; 2021 Mar; 9(3):e1593. PubMed ID: 33432707
[TBL] [Abstract][Full Text] [Related]
16. Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response.
Keefe MD; Soderholm HE; Shih HY; Stevenson TJ; Glaittli KA; Bowles DM; Scholl E; Colby S; Merchant S; Hsu EW; Bonkowsky JL
Elife; 2020 Dec; 9():. PubMed ID: 33300869
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
[TBL] [Abstract][Full Text] [Related]
18. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease.
Shimada S; Miya K; Oda N; Watanabe Y; Kumada T; Sugawara M; Shimojima K; Yamamoto T
Am J Med Genet A; 2012 Jul; 158A(7):1771-7. PubMed ID: 22678813
[TBL] [Abstract][Full Text] [Related]
19. Ovarioleukodystrophy due to EIF2B5 mutations.
Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
[TBL] [Abstract][Full Text] [Related]
20. Teaching NeuroImages: Adult-onset vanishing white matter disease.
Villar-Quiles RN; Delgado-Suárez C; Jorquera-Moya M; Arpa-Gutiérrez J; Ortega-Suero G
Neurology; 2018 Mar; 90(12):e1091-e1092. PubMed ID: 29555891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
